Tam Lori M, Fonarow Gregg C, Bhatt Deepak L, Grau-Sepulveda Maria V, Hernandez Adrian F, Peterson Eric D, Schwamm Lee H, Giugliano Robert P
Johns Hopkins Hospital, Baltimore, MD, USA.
Circ Cardiovasc Qual Outcomes. 2013 Jan 1;6(1):58-65. doi: 10.1161/CIRCOUTCOMES.112.965525. Epub 2012 Dec 11.
Secondary prevention therapies improve longitudinal outcomes in patients with coronary artery disease. Previous studies showed that teaching hospitals (THs) more consistently use evidence-based secondary prevention therapies than non-THs (NTHs). It is unclear whether these differences persist after initiation of a national quality improvement system.
We analyzed 270902 patients across 361 hospitals in the Get With The Guidelines-Coronary Artery Disease program from June 2000 to September 2009. The primary outcome was guideline-concordant care, defined as compliance with all Get With The Guidelines-Coronary Artery Disease quality measures: (1) aspirin within 24 hours, (2) aspirin at discharge, (3) angiotensin-converting enzyme inhibitor/angiotensin receptor blockers for systolic dysfunction, (4) β-blockers at discharge, (5) lipid therapy if low-density lipoprotein >100 mg/dL, and (6) smoking cessation. We used multivariate modeling to compare the relationship between TH and NTH status on quality measures, in-hospital mortality, and length of stay. Guideline-concordant care was higher at THs (78.4% versus 73.3%; P<0.01). The adjusted odds ratio between 2000 and 2009 for guideline-concordant care at THs compared with NTHs was 2.78 (confidence interval, 1.28-6.06; P=0.01). Guideline-concordant care increased from 2000 to 2009 at THs (n=176; 65.3%→88.3%; adjusted odds ratio for year increase, 1.24 [confidence interval, 1.16-1.30; P<0.01]) and NTHs (n=185; 61.0%→93.9%; adjusted odds ratio for year increase, 1.35 [confidence interval, 1.26-1.45]; P<0.01). THs had shorter length of stay (adjusted odds ratio, 0.74 for length of stay >4 days; confidence interval, 0.58-0.94) from 2000 to 2009. Lower in-hospital mortality was observed at THs (3.7% versus 4.4% at NTHs; P<0.01), but this was not significant after adjustment.
Adherence to guideline-recommended therapies increased over time with participation in the Get With The Guidelines-Coronary Artery Disease program, regardless of the teaching status. Guideline-concordant care over the full decade was higher in THs; however, NTHs demonstrated greater incremental improvement over time.
二级预防疗法可改善冠心病患者的长期预后。既往研究表明,教学医院(THs)比非教学医院(NTHs)更持续地使用循证二级预防疗法。目前尚不清楚在启动全国质量改进系统后,这些差异是否依然存在。
我们分析了2000年6月至2009年9月参与“遵循冠心病治疗指南”项目的361家医院中的270902例患者。主要结局为指南一致性治疗,定义为符合所有“遵循冠心病治疗指南”质量指标:(1)24小时内使用阿司匹林;(2)出院时使用阿司匹林;(3)对收缩功能障碍患者使用血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂;(4)出院时使用β受体阻滞剂;(5)若低密度脂蛋白>100mg/dL则进行降脂治疗;(6)戒烟。我们使用多变量模型比较教学医院和非教学医院状态与质量指标、住院死亡率及住院时间之间的关系。教学医院的指南一致性治疗更高(78.4%对73.3%;P<0.01)。2000年至2009年,教学医院与非教学医院相比,指南一致性治疗的校正比值比为2.78(置信区间为1.28 - 6.06;P = 0.01)。2000年至2009年,教学医院(n = 176;65.3%→88.3%;每年增加的校正比值比为1.24[置信区间为1.16 - 1.30;P<0.01])和非教学医院(n = 185;61.0%→93.9%;每年增加的校正比值比为1.35[置信区间为1.26 - 1.45];P<0.01)的指南一致性治疗均有所增加。2000年至2009年,教学医院的住院时间更短(住院时间>4天的校正比值比为0.74;置信区间为0.58 - 0.94)。教学医院的住院死亡率更低(3.7%对非教学医院的4.4%;P<0.01),但调整后无统计学意义。
随着参与“遵循冠心病治疗指南”项目,无论教学状态如何,遵循指南推荐疗法的情况随时间推移有所增加。在整个十年中,教学医院的指南一致性治疗更高;然而,非教学医院随时间推移显示出更大的改善幅度。